Caricamento...
Pharmacokinetic and Pharmacodynamic Responses to Clopidogrel: Evidences and Perspectives
Clopidogrel has significantly reduced the incidence of recurrent atherothrombotic events in patients with acute coronary syndrome (ACS) and in those undergoing percutaneous coronary intervention (PCI). However, recurrence events still remain, which may be partly due to inadequate platelet inhibition...
Salvato in:
| Pubblicato in: | Int J Environ Res Public Health |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5369137/ https://ncbi.nlm.nih.gov/pubmed/28335443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijerph14030301 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|